Table 1.
Author(s), Year | Country | Type of incontinence (e.g stress, urge) | Treatment (if any) | Study type (e.g. cross sectional, RCT, cohort) | Number of participants |
---|---|---|---|---|---|
Ternent et al, 2009 [20] |
UK |
Stress incontinence |
No details |
Cross sectional (self-selected sample) |
105 (of 188 approached) |
Ismail et al, 2009 [16] |
UK |
Urodynamic stress incontinence |
Magnetic energy stimulation of pelvic floor muscles |
Cohort |
48 |
Rinne et al, 2008 [22] |
Finland |
Stress UI with indications for surgical treatment |
a) Tension-free vaginal tape (TVT) |
RCT |
267 (of 273 randomised) |
b) TVT obturator (TVT-O) | |||||
Haywood et al, 2008 [7] |
UK |
Stress and/or urge incontinence in women referred for physiotherapy from primary or secondary care. |
Physiotherapy |
Cohort (RCT with data combined across arms) |
174 |
Monz et al, 2007 [12] |
15 European Countries (UK and Ireland subgroup) |
UI of any type in women seeking treatment |
At discretion of physician |
Cross-sectional data from cohort study |
9487 |
Kobelt et al, 2006 [21] |
France, Germany, Italy, Sweden, UK |
Stress UI |
NASHA/Dx gel |
Cohort |
82 of 139 enrolled |
Dumville et al, 2006 [17] |
UK |
Proven stress UI requiring surgery |
Laparoscopic vs open colposuspension |
RCT |
291 |
Currie et al , 2006 [10] |
UK |
Stress and non-stress incontinence in patients identified from sample which had been treated by urology department. |
None specified |
Cross-sectional |
609 (from 2193 sent survey) |
Monz et al, 2005 [13] |
15 European countries |
UI in women seeking treatment |
None |
Cross-sectional data from a cohort study |
9487 |
Manca et al, 2003 [18] (clinical outcomes from Ward 2002) |
UK |
Stress incontinence with indication for surgical management |
Tension-free vaginal tape vs colposuspension |
RCT |
344 |
Kobelt, 1997 [14] |
Sweden |
Mixed or urge incontinence in patients who had previously received therapy from a urotherapist. |
None specified |
Cross-sectional |
461 (541 sent questionnaire) |
Hawthorne, 2009 [2] |
Australia |
General population sample with data on presence and severity of UI |
None |
Cross-sectional |
3015 |
Tincello et al, 2010 [19] |
Germany, UK, Sweden & Ireland |
Stress UI, with or without urge symptoms, in women seeking treatment |
36.1% receiving conservative management at baseline. 18.0% receiving drug therapy at baseline. |
Cross-sectional (baseline data from cohort study) |
3739 of 3762 enrolled |
Saarni, 2006 [9] |
Finland |
Self-reported UI in general population sample |
None |
Cross-sectional |
8028 of which 13.0% reported UI |
Noble et al, 2002 [11] |
UK |
Uncomplicated urinary tract symptoms in men with benign prostatic enlargement |
Laser therapy vs Transurethral prostrate resection vs conservative management |
RCT |
340 |
Mihaylova et al, 2010 [23] |
Multicountry |
Stress UI |
Duloxetine vs conservative management vs duloxetine plus conservative management vs no treatment |
Cohort (non randomised comparison of treatments) |
1510 |
(Germany, UK & Sweden) |
40% had pure stress incontinence with the rest reporting both stress and urge incontinence |
||||
Donovan et al, 1997 [8] | 12 countries | Outpatients attending urology department with symptoms (not specifically incontinence) and possible benign prostatic obstruction. GP sample (not selected for condition) | None | Cross-sectional | 1271 outpatient sample |
423 GP sample (UK) |
GP=General Practice NASHA/Dx =non-animal-stabilized hyaluronic acid/dextranome, RCT=randomised controlled trial, UI=urinary incontinence, UK=United Kingdom.